Cargando…

Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls

Mineralocorticoid receptors (MR) are predominantly expressed in the hippocampus and prefrontal cortex. Both brain areas are associated with social cognition, which includes cognitive empathy (ability to understand others’ emotions) and emotional empathy (ability to empathize with another person). MR...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowacki, Jan, Wingenfeld, Katja, Kaczmarczyk, Michael, Chae, Woo Ri, Abu-Tir, Ikram, Deuter, Christian Eric, Piber, Dominique, Hellmann-Regen, Julian, Otte, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785026/
https://www.ncbi.nlm.nih.gov/pubmed/32722659
http://dx.doi.org/10.1038/s41386-020-0777-x
_version_ 1783632377034047488
author Nowacki, Jan
Wingenfeld, Katja
Kaczmarczyk, Michael
Chae, Woo Ri
Abu-Tir, Ikram
Deuter, Christian Eric
Piber, Dominique
Hellmann-Regen, Julian
Otte, Christian
author_facet Nowacki, Jan
Wingenfeld, Katja
Kaczmarczyk, Michael
Chae, Woo Ri
Abu-Tir, Ikram
Deuter, Christian Eric
Piber, Dominique
Hellmann-Regen, Julian
Otte, Christian
author_sort Nowacki, Jan
collection PubMed
description Mineralocorticoid receptors (MR) are predominantly expressed in the hippocampus and prefrontal cortex. Both brain areas are associated with social cognition, which includes cognitive empathy (ability to understand others’ emotions) and emotional empathy (ability to empathize with another person). MR stimulation improves memory and executive functioning in patients with major depressive disorder (MDD) and healthy controls, and leads to glutamate-mediated N-methyl-D-aspartate receptor (NMDA-R) signaling. We examined whether the beneficial effects of MR stimulation can be extended to social cognition (empathy), and whether DCS would have additional beneficial effects. In this double-blind placebo-controlled single-dose study, we randomized 116 unmedicated MDD patients (mean age 34 years, 78% women) and 116 age-, sex-, and education years-matched healthy controls to four conditions: MR stimulation (fludrocortisone (0.4 mg) + placebo), NMDA-R stimulation (placebo + D-cycloserine (250 mg)), MR and NMDA-R stimulation (both drugs), or placebo. Cognitive and emotional empathy were assessed by the Multifaceted Empathy Test. The study was registered on clinicaltrials.gov (NCT03062150). MR stimulation increased cognitive empathy across groups, whereas NMDA-R stimulation decreased cognitive empathy in MDD patients only. Independent of receptor stimulation, cognitive empathy did not differ between groups. Emotional empathy was not affected by MR or NMDA-R stimulation. However, MDD patients showed decreased emotional empathy compared with controls but, according to exploratory analyses, only for positive emotions. We conclude that MR stimulation has beneficial effects on cognitive empathy in MDD patients and healthy controls, whereas NMDA-R stimulation decreased cognitive empathy in MDD patients. It appears that MR rather than NMDA-R are potential treatment targets to modulate cognitive empathy in MDD.
format Online
Article
Text
id pubmed-7785026
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-77850262021-01-14 Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls Nowacki, Jan Wingenfeld, Katja Kaczmarczyk, Michael Chae, Woo Ri Abu-Tir, Ikram Deuter, Christian Eric Piber, Dominique Hellmann-Regen, Julian Otte, Christian Neuropsychopharmacology Article Mineralocorticoid receptors (MR) are predominantly expressed in the hippocampus and prefrontal cortex. Both brain areas are associated with social cognition, which includes cognitive empathy (ability to understand others’ emotions) and emotional empathy (ability to empathize with another person). MR stimulation improves memory and executive functioning in patients with major depressive disorder (MDD) and healthy controls, and leads to glutamate-mediated N-methyl-D-aspartate receptor (NMDA-R) signaling. We examined whether the beneficial effects of MR stimulation can be extended to social cognition (empathy), and whether DCS would have additional beneficial effects. In this double-blind placebo-controlled single-dose study, we randomized 116 unmedicated MDD patients (mean age 34 years, 78% women) and 116 age-, sex-, and education years-matched healthy controls to four conditions: MR stimulation (fludrocortisone (0.4 mg) + placebo), NMDA-R stimulation (placebo + D-cycloserine (250 mg)), MR and NMDA-R stimulation (both drugs), or placebo. Cognitive and emotional empathy were assessed by the Multifaceted Empathy Test. The study was registered on clinicaltrials.gov (NCT03062150). MR stimulation increased cognitive empathy across groups, whereas NMDA-R stimulation decreased cognitive empathy in MDD patients only. Independent of receptor stimulation, cognitive empathy did not differ between groups. Emotional empathy was not affected by MR or NMDA-R stimulation. However, MDD patients showed decreased emotional empathy compared with controls but, according to exploratory analyses, only for positive emotions. We conclude that MR stimulation has beneficial effects on cognitive empathy in MDD patients and healthy controls, whereas NMDA-R stimulation decreased cognitive empathy in MDD patients. It appears that MR rather than NMDA-R are potential treatment targets to modulate cognitive empathy in MDD. Springer International Publishing 2020-07-28 2020-12 /pmc/articles/PMC7785026/ /pubmed/32722659 http://dx.doi.org/10.1038/s41386-020-0777-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Nowacki, Jan
Wingenfeld, Katja
Kaczmarczyk, Michael
Chae, Woo Ri
Abu-Tir, Ikram
Deuter, Christian Eric
Piber, Dominique
Hellmann-Regen, Julian
Otte, Christian
Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls
title Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls
title_full Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls
title_fullStr Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls
title_full_unstemmed Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls
title_short Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls
title_sort cognitive and emotional empathy after stimulation of brain mineralocorticoid and nmda receptors in patients with major depression and healthy controls
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785026/
https://www.ncbi.nlm.nih.gov/pubmed/32722659
http://dx.doi.org/10.1038/s41386-020-0777-x
work_keys_str_mv AT nowackijan cognitiveandemotionalempathyafterstimulationofbrainmineralocorticoidandnmdareceptorsinpatientswithmajordepressionandhealthycontrols
AT wingenfeldkatja cognitiveandemotionalempathyafterstimulationofbrainmineralocorticoidandnmdareceptorsinpatientswithmajordepressionandhealthycontrols
AT kaczmarczykmichael cognitiveandemotionalempathyafterstimulationofbrainmineralocorticoidandnmdareceptorsinpatientswithmajordepressionandhealthycontrols
AT chaewoori cognitiveandemotionalempathyafterstimulationofbrainmineralocorticoidandnmdareceptorsinpatientswithmajordepressionandhealthycontrols
AT abutirikram cognitiveandemotionalempathyafterstimulationofbrainmineralocorticoidandnmdareceptorsinpatientswithmajordepressionandhealthycontrols
AT deuterchristianeric cognitiveandemotionalempathyafterstimulationofbrainmineralocorticoidandnmdareceptorsinpatientswithmajordepressionandhealthycontrols
AT piberdominique cognitiveandemotionalempathyafterstimulationofbrainmineralocorticoidandnmdareceptorsinpatientswithmajordepressionandhealthycontrols
AT hellmannregenjulian cognitiveandemotionalempathyafterstimulationofbrainmineralocorticoidandnmdareceptorsinpatientswithmajordepressionandhealthycontrols
AT ottechristian cognitiveandemotionalempathyafterstimulationofbrainmineralocorticoidandnmdareceptorsinpatientswithmajordepressionandhealthycontrols